MediSpend recently acquired Real Life Sciences (RLS), the leading provider of clinical data and documents anonymization and redaction for the life sciences industry. Their platform, RLS Protect, is the industry leading solution which helps trial sponsors prepare required regulatory disclosure submissions and clinical data for sharing purposes.
Listen as Elliot Zimmerman, CEO of RLS, shares more about the regulatory landscape for data anonymization, the power of RLS Protect and how RLS’ clients leverage their innovative solutions and services.